Skip to content

Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression

Taylor Lyons, Robin Carhart-Harris

Journal of Psychopharmacology January 17, 2018 DOI: 10.1177/0269881117748902 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Open-label pilot study with mixed-model design Peer reviewed
Sample size 14
Population Patients with moderate to severe treatment-resistant depression (n=7) and age-matched healthy control subjects (n=7)
Intervention Psilocybin
Dose 10 mg and 25 mg
Duration Two dosing sessions 1 week apart, with follow-up at 1 week and 7–12 months after the second session
Topics Psilocybin Depression
Keywords Authoritarianism Dosing Depression economics Clinical psychology Politics Hallucinogen
Citations 176
Key points Psilocybin increased nature relatedness and decreased authoritarianism in patients with treatment-resistant depression, with the increase in nature relatedness persisting for 7–12 months.

Abstract

Rationale: Previous research suggests that classical psychedelic compounds can induce lasting changes in personality traits, attitudes and beliefs in both healthy subjects and patient populations.

Aim: Here we sought to investigate the effects of psilocybin on nature relatedness and libertarian–authoritarian political perspective in patients with treatment-resistant depression (TRD).

Methods: This open-label pilot study with a mixed-model design studied the effects of psilocybin on measures of nature relatedness and libertarian–authoritarian political perspective in patients with moderate to severe TRD ( n=7) versus age-matched non-treated healthy control subjects ( n=7). Psilocybin was administered in two oral dosing sessions (10 mg and 25 mg) 1 week apart. Main outcome measures were collected 1 week and 7–12 months after the second dosing session. Nature relatedness and libertarian–authoritarian political perspective were assessed using the Nature Relatedness Scale (NR-6) and Political Perspective Questionnaire (PPQ-5), respectively.

Results: Nature relatedness significantly increased ( t(6)=−4.242, p=0.003) and authoritarianism significantly decreased ( t(6)=2.120, p=0.039) for the patients 1 week after the dosing sessions. At 7–12 months post-dosing, nature relatedness remained significantly increased ( t(5)=−2.707, p=0.021) and authoritarianism remained decreased at trend level ( t(5)=−1.811, p=0.065). No differences were found on either measure for the non-treated healthy control subjects.

Conclusions: This pilot study suggests that psilocybin with psychological support might produce lasting changes in attitudes and beliefs. Although it would be premature to infer causality from this small study, the possibility of drug-induced changes in belief systems seems sufficiently intriguing and timely to deserve further investigation.

Comparable studies

Other non-randomized and open-label trials on psilocybin for depression, most cited first.

Study Year Design Participants
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Patients with moderate-to-severe, unipolar, treatment-resistant major depression 2016 Open-label feasibility trial n = 12
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Patients with severe, unipolar, treatment-resistant major depression 2017 Open-label trial n = 20
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Patients with major depressive disorder 2021 Open-label study n = 24
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. Individuals diagnosed with moderate to severe, treatment-resistant depression 2017 Open-label study n = 20

Explore topics

By condition and practice